Streetbeat News

INLB

Item 9 Labs Corp

Employees

104

Industry

Dental Equipment and Supplies Manufacturing

Open

0.00

Mkt cap

70K

Volume

20K

High

0.00

P/E Ratio

N/A

52-wk high

0.00

Low

0.00

Div yield

N/A

52-wk low

0.00

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

The cannabis sector experienced significant movements on June 3, 2024, with notable gainers and losers. Key gainers include Eastside Distilling (NASDAQ:EAST), Corbus Pharmaceuticals (NASDAQ:CRBP), and Cara Therapeutics (NASDAQ:CARA). Major losers include Scotts Miracle Gro (NYSE:SMG), Village Farms Intl (NASDAQ:VFF), and Canopy Growth (NASDAQ:CGC).

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:30 pm

Marijuana stocks experienced significant movement with Target Group, Global Compliance, and Heritage Cannabis Holding among the top gainers, while Item 9 Labs and Global Hemp Group led the losers. Notable NASDAQ-listed companies like Psychemedics, SNDL, Genetic Technologies, Urban-gro, Village Farms Intl, Canopy Growth, and Greenlane Holdings also saw varied price changes.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 8:30 pm

Marijuana stocks experienced significant movements with Elixinol Wellness, Item 9 Labs, and Canopy Growth among the top gainers, while Charlotte's Web Holdings and Pharmadrug led the losers. The market saw a bullish trend for cannabis companies, with notable increases in stock prices for many firms listed on both OTC and NASDAQ.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 8:30 pm

Marijuana stocks saw significant movement on April 17, 2024, with notable gainers including Green Growth Brands and Elixinol Wellness, and losers like Khiron Life Sciences and Item 9 Labs. The movements reflect volatility in the cannabis sector, impacting companies listed on both OTC and major exchanges like NASDAQ and NYSE.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 8:30 pm

The article reports on the significant gainers and losers among cannabis stocks for April 16, 2024. Notable gainers include Global Hemp Group, Heritage Cannabis Holding, and Indiva, with increases of 66.67%, 28.57%, and 24.32% respectively. On the losing end, Item 9 Labs, Zoned Props, and Greenlane Holdings saw declines of 33.33%, 18.33%, and 12.44%. The article highlights the volatility in the cannabis sector, with several companies experiencing notable changes in their stock prices.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 8:30 pm

Marijuana stocks saw significant movement on April 11, 2024, with notable gainers including Belgravia Hartford Cap, Item 9 Labs, and Greenlane Holdings, among others. Losers for the day included Target Group, Rocky Mountain High, and Canopy Growth. The movements reflect the volatile nature of the marijuana stock market.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on April 10, 2024, with notable gainers including Khiron Life Sciences, Heritage Cannabis, and Village Farms International. Losers of the day included Item 9 Labs, SOL Global Investments, and Scotts Miracle Gro. The movements reflect volatility in the cannabis market, impacting investors and companies alike.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on April 9, 2024, with notable gainers including Target Group, iAnthus Capital Holdings, and Greenlane Holdings, among others. Conversely, GreenGro Technologies led the losers, followed by Heritage Cannabis Holding and Elixinol Wellness. The volatility reflects ongoing market adjustments within the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.